Immunoproteasome inhibitors and immunoinhibitors in treatment of autoimmune disorders

The present invention relates to immunoproteasome inhibitors and immunosuppressants in the treatment of autoimmune disorders. Provided herein are methods of treating an autoimmune disease comprising administering an immunoproteasome inhibitor and an immunosuppressive agent to a subject suffering fro...

Full description

Saved in:
Bibliographic Details
Main Author MUCHMIEL, THOMAS
Format Patent
LanguageChinese
English
Published 05.01.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to immunoproteasome inhibitors and immunosuppressants in the treatment of autoimmune disorders. Provided herein are methods of treating an autoimmune disease comprising administering an immunoproteasome inhibitor and an immunosuppressive agent to a subject suffering from the autoimmune disease. 本发明涉及自身免疫性病症的治疗中的免疫蛋白酶体抑制剂和免疫抑制剂。本文提供了治疗自身免疫性疾病的方法,其包括向患有所述自身免疫性疾病的受试者施用免疫蛋白酶体抑制剂和免疫抑制剂。
Bibliography:Application Number: CN202311223954